Evidence map›Paper›PMID 37233496›Full record

ArticleMarine drugs2023

Fucoidan from

Lingzhi Wang, Catarina Oliveira, Qiu Li, Andreia S Ferreira, Cláudia Nunes, Manuel A Coimbra, Rui L Reis, Albino Martins, Chunming Wang, Tiago H Silva and 1 more

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Enzymatic Hydrolysates fromMarine drugs · 2026
    Article
  3. From Sea to Cell:Marine drugs · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Fucoidan fromFrontiers in pharmacology · 2025
    Article
  13. Review
  14. Article
  15. Effects of Fucoidans on Activated Retinal Microglia.International journal of molecular sciences · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Lingzhi WangSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529000, China.
Catarina Oliveira3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barco, 4805-017 Guimarães, Portugal.
Qiu LiState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Andreia S FerreiraLAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal.ORCID 0000-0002-0321-2207
Cláudia NunesCICECO, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal.ORCID 0000-0001-7217-2790
Manuel A CoimbraLAQV-REQUIMTE, Department of Chemistry, University of Aveiro, Campus de Santiago, 3810-193 Aveiro, Portugal.ORCID 0000-0001-8898-6342
Rui L Reis3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barco, 4805-017 Guimarães, Portugal.ORCID 0000-0002-4295-6129
Albino Martins3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barco, 4805-017 Guimarães, Portugal.ORCID 0000-0003-3868-0251
Chunming WangState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, China.
Tiago H Silva3B's Research Group, I3Bs-Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, Barco, 4805-017 Guimarães, Portugal.ORCID 0000-0001-8520-603X
Yanxian FengSchool of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529000, China.
University of Minho · PTUniversity of Macau · MORede de Química e Tecnologia · PTUniversity of Aveiro · PTWuyi University · CN

Funding

Fundação para a Ciência e Tecnologia LA/P/0006/2020Fundação para a Ciência e Tecnologia SFRH/BD/102471/2014Fundação para a Ciência e Tecnologia UIDB/50006/2020Fundação para a Ciência e Tecnologia UIDB/50011/2020Fundação para a Ciência e Tecnologia UIDP/50011/2020INTERREG España-Portugal 2014-2020 0474_BLUEBIOLAB_1_ENational Natural Science Foundation of China 32000936Norte 2020 "ATLANTIDA", NORTE-01-0145-FEDER-000040
6 · The paper itself

Abstract

Fucoidan has been reported to present diverse bioactivities, but each extract has specific features from which a particular biological activity, such as immunomodulation, must be confirmed. In this study a commercially available pharmaceutical-grade fucoidan extracted from

Indexed as

FucusAnimalsCytokinesLipopolysaccharidesMicePolysaccharidesCytokinesfucoidanLipopolysaccharidesPolysaccharidesanti-inflammatoryfucoidanFucus vesiculosusmacrophage

Identifiers

PMID37233496
PMCPMC10221219
OpenAlexW4376875120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.